Haemonetics HAE Rest of Asia — Net revenues

Similar metrics at other companies

EBAYRest of world — Net revenues

$660M+3.4%

ROP

ROPAsia — Net revenues

$17.78M-4.0%

ROP

ROPRest of the world — Net revenues

$31.38M+6.0%

FIGSRest of the world — Net revenues

$37.89M+67.0%

HASAsia Pacific — Net revenues

$53.2M-16.4%

TTAsia Pacific — Net revenues

$384.6M+11.1%

FAQ

What is Haemonetics's rest of asia — net revenues?

Haemonetics (HAE) reported rest of asia — net revenues of $20.16M in Q2 2026.

How has Haemonetics's rest of asia — net revenues changed year-over-year?

Haemonetics's rest of asia — net revenues decreased by 6.9% year-over-year, from $21.65M to $20.16M.

What does rest of asia — net revenues mean?

This metric represents the total net revenue generated from sales of medical products and solutions within the Asian geographic market. It reflects the company's regional market penetration and the adoption rate of its blood and plasma component collection technologies in these specific territories. Monitoring this figure helps investors assess the company's international growth strategy and its ability to capture market share in emerging or established healthcare systems outside of its primary domestic markets.